Alzheimer’s catalysts round off a year dominated by Biogen

Alzheimer’s catalysts round off a year dominated by Biogen

Source: 
EP Vantage
snippet: 

Clinical data near for Alzheimer’s antibodies from Roche and Lilly, while Cortexyme and Biohaven test small molecules.